224 related articles for article (PubMed ID: 32538252)
21. Acute effects of MDMA on autonomic cardiac activity and their relation to subjective prosocial and stimulant effects.
Clark CM; Frye CG; Wardle MC; Norman GJ; de Wit H
Psychophysiology; 2015 Mar; 52(3):429-35. PubMed ID: 25208727
[TBL] [Abstract][Full Text] [Related]
22. The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
Tancer M; Johanson CE
Psychopharmacology (Berl); 2007 Jan; 189(4):565-73. PubMed ID: 17047932
[TBL] [Abstract][Full Text] [Related]
23. MDMA: a social drug in a social context.
Kirkpatrick MG; de Wit H
Psychopharmacology (Berl); 2015 Mar; 232(6):1155-63. PubMed ID: 25281223
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.
Hysek CM; Simmler LD; Schillinger N; Meyer N; Schmid Y; Donzelli M; Grouzmann E; Liechti ME
Int J Neuropsychopharmacol; 2014 Mar; 17(3):371-81. PubMed ID: 24103254
[TBL] [Abstract][Full Text] [Related]
25. The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.
Kamilar-Britt P; Bedi G
Neurosci Biobehav Rev; 2015 Oct; 57():433-46. PubMed ID: 26408071
[TBL] [Abstract][Full Text] [Related]
26. Chemical cousins with contrasting behavioural profiles: MDMA users and methamphetamine users differ in social-cognitive functions and aggression.
Zacher A; Zimmermann J; Cole DM; Friedli N; Opitz A; Baumgartner MR; Steuer AE; Verdejo-Garcia A; Stock AK; Beste C; Quednow BB
Eur Neuropsychopharmacol; 2024 Jun; 83():43-54. PubMed ID: 38642447
[TBL] [Abstract][Full Text] [Related]
27. Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart.
Farré M; Tomillero A; Pérez-Mañá C; Yubero S; Papaseit E; Roset PN; Pujadas M; Torrens M; Camí J; de la Torre R
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1637-49. PubMed ID: 26073279
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.
Farré M; Abanades S; Roset PN; Peiró AM; Torrens M; O'Mathúna B; Segura M; de la Torre R
J Pharmacol Exp Ther; 2007 Dec; 323(3):954-62. PubMed ID: 17890444
[TBL] [Abstract][Full Text] [Related]
29. Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans.
Kirkpatrick MG; Francis SM; Lee R; de Wit H; Jacob S
Psychoneuroendocrinology; 2014 Aug; 46():23-31. PubMed ID: 24882155
[TBL] [Abstract][Full Text] [Related]
30. Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects.
Dolder PC; Müller F; Schmid Y; Borgwardt SJ; Liechti ME
Psychopharmacology (Berl); 2018 Feb; 235(2):467-479. PubMed ID: 28551715
[TBL] [Abstract][Full Text] [Related]
31. Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected.
Kuypers KP; Ramaekers JG
Psychopharmacology (Berl); 2007 Jan; 189(4):557-63. PubMed ID: 16508761
[TBL] [Abstract][Full Text] [Related]
32. MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study.
Parrott AC; Gibbs A; Scholey AB; King R; Owens K; Swann P; Ogden E; Stough C
Psychopharmacology (Berl); 2011 Jun; 215(3):527-36. PubMed ID: 21318566
[TBL] [Abstract][Full Text] [Related]
33. Gender differences in the subjective effects of MDMA.
Liechti ME; Gamma A; Vollenweider FX
Psychopharmacology (Berl); 2001 Mar; 154(2):161-8. PubMed ID: 11314678
[TBL] [Abstract][Full Text] [Related]
34. Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants.
Straumann I; Ley L; Holze F; Becker AM; Klaiber A; Wey K; Duthaler U; Varghese N; Eckert A; Liechti ME
Neuropsychopharmacology; 2023 Dec; 48(13):1840-1848. PubMed ID: 37258715
[TBL] [Abstract][Full Text] [Related]
35. Human Pharmacology of Mephedrone in Comparison with MDMA.
Papaseit E; Pérez-Mañá C; Mateus JA; Pujadas M; Fonseca F; Torrens M; Olesti E; de la Torre R; Farré M
Neuropsychopharmacology; 2016 Oct; 41(11):2704-13. PubMed ID: 27206266
[TBL] [Abstract][Full Text] [Related]
36. 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.
Hernández-López C; Farré M; Roset PN; Menoyo E; Pizarro N; Ortuño J; Torrens M; Camí J; de La Torre R
J Pharmacol Exp Ther; 2002 Jan; 300(1):236-44. PubMed ID: 11752122
[TBL] [Abstract][Full Text] [Related]
37. Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors.
van Wel JH; Kuypers KP; Theunissen EL; Bosker WM; Bakker K; Ramaekers JG
PLoS One; 2012; 7(7):e40187. PubMed ID: 22808116
[TBL] [Abstract][Full Text] [Related]
38. Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or 'ecstasy' and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices.
Kamboj SK; Kilford EJ; Minchin S; Moss A; Lawn W; Das RK; Falconer CJ; Gilbert P; Curran HV; Freeman TP
J Psychopharmacol; 2015 Sep; 29(9):961-70. PubMed ID: 25990558
[TBL] [Abstract][Full Text] [Related]
39. Differential sensitivity to detect prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA) in different social approach paradigms in mice.
Mukai S; Nakada S; Kamada H; Yaguchi R; Deyama S; Kaneda K
Neuropsychopharmacol Rep; 2020 Sep; 40(3):297-301. PubMed ID: 32608059
[TBL] [Abstract][Full Text] [Related]
40. Does ±3,4-methylenedioxymethamphetamine (ecstasy) induce subjective feelings of social connection in humans? A multilevel meta-analysis.
Regan A; Margolis S; de Wit H; Lyubomirsky S
PLoS One; 2021; 16(10):e0258849. PubMed ID: 34695117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
